Noresmea (Norethisterone Acetate, Estradiol)

Norethisterone acetate acts as a synthetic progestogen, binding to progesterone receptors to suppress the luteinising hormone surge and stabilize the endometrium. Estradiol provides estrogenic activity by binding to estrogen receptors, replacing deficient estrogen and supporting the menstrual cycle.

The prescribed dose of Noresmea is determined by the treating clinician based on the individual’s medical condition and therapeutic goals. Patients should follow the prescriber’s instructions and not alter the dosing regimen without medical advice.

Noresmea is contraindicated in pregnancy because it contains hormonal agents that can affect fetal development. Its safety during breastfeeding has not been established, and a healthcare professional should be consulted before use in lactating women.

To order Noresmea, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noresmea contains a specific 1 mg norethisterone acetate and 2 mg estradiol combination, offering both progestogenic and estrogenic activity. Compared with other combined oral contraceptives that may use different progestins or ethinyl estradiol, Noresmea provides a natural estradiol component, which may have a different side‑effect profile and metabolic impact.

Noresmea tablets should be stored at ambient temperature below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and store out of reach of children.

Noresmea is taken orally, usually once daily at the same time each day, as directed by a healthcare professional. The tablet should be swallowed whole with water and not chewed or crushed.

The most serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe hypertension, hepatic dysfunction, and rare allergic reactions. Patients should seek immediate medical attention if they experience symptoms like sudden leg pain, chest discomfort, severe headache, jaundice, or rash.

Noresmea should not be used by women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known estrogen‑dependent tumors, or those who are pregnant. It is also contraindicated in individuals with known hypersensitivity to norethisterone acetate, estradiol, or any tablet excipients.